Table 2 Tissue optical properties for each region in the 3D model at two activation wavelengths (\(\lambda _1 = 690\) nm and \(\lambda _2 = 565\) nm).
From: Photodynamic therapy outcome modelling for patients with spinal metastases: a simulation-based study
Tissue | \(\lambda _1 = 690\) nm | \(\lambda _2 = 565\) nm | ||||||
|---|---|---|---|---|---|---|---|---|
\(\mu _s\) (mm\(^{-1}\)) | \(\mu _a\) (mm\(^{-1}\)) | g | n | \(\mu _s\) (mm\(^{-1}\)) | \(\mu _a\) (mm\(^{-1}\)) | g | n | |
Spinal cord | 15.47 | 0.0216 | 0.9 | 1.41 | 22.48 | 0.108 | 0.9 | 1.41 |
Bone | 15.23 | 0.01 | 0.9 | 1.56 | 32.09 | 0.04 | 0.9 | 1.56 |
Sclerotic metastasis\(^{\mathrm{a}}\) | 15.23 | 0.01 | 0.9 | 1.56 | 32.09 | 0.04 | 0.9 | 1.56 |
Osteolytic metastasis | 16 | 0.009 | 0.9 | 1.56 | 10.22 | 0.09 | 0.9 | 1.56 |
Muscle | 7.356 | 0.052 | 0.93 | 1.41 | 11.61 | 0.36 | 0.93 | 1.41 |
